GILD

Gilead Sciences, Inc. News Headlines

$103.06
*  
0.27
0.26%
Get GILD Alerts
*Delayed - data as of Mar. 4, 2015  -  Find a broker to begin trading GILD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    GILD After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Why You Shouldn't Bet Against Gilead Sciences (GILD) Stock - Tale of the Tape
11/25/2014 8:59:00 AM - Zacks.com


3 Biotech Growth Stocks You Can Buy Right Now
11/25/2014 8:17:02 AM - Motley Fool


AbbVie Takes Aim at Gilead Sciences
11/25/2014 8:01:04 AM - Motley Fool


Be Careful With Gilead - It May Be Time To Take Profits
11/25/2014 7:10:00 AM - Seeking Alpha


AbbVie's HCV Cocktail Treatment Closer to EU Approval - Analyst Blog
11/24/2014 7:00:00 PM - Zacks.com


Can Partnering To Fight Hepatitis C Pay At Enanta?
11/24/2014 4:44:00 PM - Investor's Business Daily


3 Biotech Stocks That Could Soar Even Higher
11/24/2014 3:44:02 PM - Motley Fool


Investors Should Be Concerned About Gilead
11/24/2014 1:37:00 PM - Seeking Alpha


Gilead Sciences Inc. Just Paid $125 Million for Something It Can't Use for a Year
11/24/2014 7:53:03 AM - Motley Fool


Get Your Wallet Out: Global Drug Spending is About to Hit a Dubious Milestone
11/23/2014 10:18:03 AM - Motley Fool


This May Be the Fastest Growing Big Biotech Stock Next Year (Hint: It's Not Gilead Sciences)
11/22/2014 1:47:02 PM - Motley Fool


This Time I Really Mean It
11/22/2014 10:30:00 AM - Seeking Alpha


Gilead to Buy Knight Therapeutics' Priority Review Voucher - Analyst Blog
11/20/2014 4:27:00 PM - Zacks.com


Notable ETF Inflow Detected - VTI, BAC, GILD, INTC
11/20/2014 11:14:34 AM - BNK Invest


Biotech's 3 Most Influential CEOs
11/20/2014 10:20:03 AM - Motley Fool


Nasdaq 100 Movers: TSLA, SPLS
11/19/2014 1:09:37 PM - BNK Invest


Gilead: Pipeline Now Includes Potential Renal Blockbuster
11/19/2014 11:35:00 AM - Seeking Alpha


Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in the EU - Analyst Blog
11/19/2014 11:23:00 AM - Zacks.com


Update: Gilead's Harvoni Receives Marketing Authorization In Europe
11/19/2014 11:17:00 AM - Seeking Alpha


Stock Market News for November 19, 2014 - Market News
11/19/2014 10:10:00 AM - Zacks.com


Gilead: Rising Net Income, Zero Debt And Strong R&D Pipeline
11/19/2014 7:45:00 AM - Seeking Alpha


Gilead's Value Without Its Hep C Franchise
11/18/2014 4:07:00 PM - Seeking Alpha


Buy Gilead Sciences Now At A Historic Low Valuation
11/18/2014 8:52:00 AM - Seeking Alpha


Dispelling Some Of The Myths Surrounding Gilead Sciences.
11/18/2014 8:22:00 AM - Seeking Alpha


Incyte Building Blockbuster Drug One Disease At A Time
11/17/2014 3:58:00 PM - Investor's Business Daily